Jun 13, 2023 / 11:00PM GMT
Rajan Sharma - Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. Good afternoon, everyone. My name is Rajan Sharma. I'm one of the European biotech analyst here at Goldman Sachs. I'm pleased to have Christian Itin, who's the CEO at Autolus, join us for a fireside this afternoon. Christian, thank you for taking the time. Maybe you want to kind of start by giving a high-level overview of Autolus and kind of the technology platforms that you have.
Christian Martin Itin - Autolus Therapeutics plc - CEO & Director
Yes, happy to do that. First of all, thanks for the invitation. Always great to come out of California and get a bit of (inaudible), although the June gloom certainly had its moments this morning. I'm Christian Itin, CEO of Autolus. We had a very exciting last few months actually behind us. We're just coming off ASCO, where we had shown pivotal data for our LEAP program called Obe-cel that we developed in patients with acute lymphoblastic leukemia, had very nice data, very good safety profile, high level of activity. And as you
Autolus Therapeutics PLC at Goldman Sachs Healthcare Conference Transcript
Jun 14, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers